Destiny Pharma PLC (LSE:DEST) - Share price - Overview


Stock Report

Destiny Pharma PLC DEST

Last Price
GBX82.50

Day Change
0.50|0.61%

As of 25/03/2019
16:15:47 GMT | GBX
Minimum 15 Minutes Delay.

Last Close82.00p
Day Range81.00 - 84.00
Mkt Cap36.04Mil
52-Wk Range61.00 - 131.40
Yield %-
ISINGB00BDHSP575
Volume10,755
P/E-11.63
P/SInfinity
P/CF-0.14

Share Price

Total Returns 25/03/2019

 Chg (%)  
More ...
Destiny Pharma PLC3.13 
FTSE 100 TR GBP1.16
 
Financials
201520162017
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-1.21-1.45-2.72
Net Profit-1.02-1.26-2.98
Reported EPS-2.443.02-8.40
Balance Sheet
Current Assets1.341.7017.06
Non Current Assets0.000.000.02
Total Assets1.351.7017.08
Current Liabilities0.090.160.40
Total Liabilities---
Total Equity1.251.5416.69
Cash Flow
Operating Cash Flow-1.08-1.17-2.35
Net Change in Cash-0.890.3610.24
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
04/06/2018PurchaseSir Anthony Nigel Russell Rudd DL110.0439,10043,026.00
04/06/2018PurchaseSir Anthony Nigel Russell Rudd DL110.0435,80039,394.00

Company Profile

Destiny Pharma PLC is a clinical stage biotechnology company. It is engaged in the development of new anti-microbial drugs to address the growing and unmet demand for prophylaxis and treatment of life-threatening drug-resistant bacteria.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 09/04/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-16.33
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr. Neil Robert Clark
Executive Director, Chief Financial Officer and Company SecretaryShaun Claydon
Executive Director, Chief Scientific OfficerDr. William Guy Love
Non-Executive DirectorMr. Anthony Joseph Eagle
Non-Executive DirectorMr. Peter Morgan
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.